AbbVie Can't Dodge Consumers' Claims In Testosterone MDL
AbbVie Inc. and Abbott Laboratories must face the bulk of claims brought by seven people whose cases were selected for bellwether trials in multidistrict litigation over the safety of testosterone gel products,...To view the full article, register now.
Already a subscriber? Click here to view full article